oncology

Report: Illumina in Talks to Acquire Cancer Diagnostics Startup Grail
Report: Illumina in Talks to Acquire Cancer Diagnostics Startup Grail
Motley Fool
M&A
diagnostics
cancer diagnostics
cancer
oncology
Illumina
Grail
Flag link:
Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations
Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations
Biopharma Reporter
Merck
Seattle Genetics
cancer
oncology
ADCs
Tukysa
ladiratuzumab vedotin
Flag link:
Exelixis, NBE join forces for discovery and development of ADCs for cancer
Exelixis, NBE join forces for discovery and development of ADCs for cancer
Pharmaceutical Business Review
Exelixis
NBE Therapeutics
antibody-drug conjugate
oncology
Flag link:
Astellas puts health inequality front and center in cancer innovation challenge's 5th year
Astellas puts health inequality front and center in cancer innovation challenge's 5th year
Fierce Pharma
Astellas
oncology
innovation
innovation challenges
Flag link:
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies
Xconomy
Kinnate Biopharma
cancer
oncology
Flag link:
Gilead expands Tango alliance, continuing a busy year of cancer deals
Gilead expands Tango alliance, continuing a busy year of cancer deals
Biopharma Dive
Gilead Sciences
Tango Therapeutics
oncology
Flag link:
Achilles Heel of Immunotherapy-Resistant Cancers Revealed – and Eliminated – in Early Studies
Achilles Heel of Immunotherapy-Resistant Cancers Revealed – and Eliminated – in Early Studies
BioSpace
cancer
oncology
immunotherapy-resistant cancer
Flag link:
Tarveda’s Phase II Miniature Drug Conjugates Deliver Better Targeting, Less Toxicity than ADCs
Tarveda’s Phase II Miniature Drug Conjugates Deliver Better Targeting, Less Toxicity than ADCs
BioSpace
Tarveda Therapeutics
miniature drug conjugates
Pentarin
oncology
solid tumors
Flag link:
GSK’s John Fleming on rethinking oncology from the ground up
GSK’s John Fleming on rethinking oncology from the ground up
Pharmaforum
GSK
oncology
cancer
Flag link:
Sanofi keeps foot on the gas, agreeing to five-year collaboration with MD Anderson
Sanofi keeps foot on the gas, agreeing to five-year collaboration with MD Anderson
Endpoints
MD Anderson Cancer Center
Sanofi
clinical trials
oncology
Flag link:
Vor Biopharma Snags $110 Million to Advance AML Treatment into the Clinic
Vor Biopharma Snags $110 Million to Advance AML Treatment into the Clinic
BioSpace
Vor Biopharma
funding
stem cells
clinical trials
oncology
AML
Flag link:
Sumitomo merges U.S. biotechs to create oncology division
Sumitomo merges U.S. biotechs to create oncology division
Fierce Biotech
Sumitomo Dainippon
Tolero Pharmaceuticals
Boston Biomedical
oncology
M&A
Flag link:
Athenex features real patients in first oncology campaign as it readies key breast cancer filing
Athenex features real patients in first oncology campaign as it readies key breast cancer filing
Fierce Pharma
oncology
Athenex
metastatic breast cancer
patients
Flag link:
GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
Fierce Biotech
GSK
cancer
R&D
oncology
Ideaya
genome editing
Flag link:
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track
Xconomy
GSK
oncology
Zejula
niraparib
belantamab mafodotin
dostarlimab
immuno-oncology
Flag link:
Eight Fraudulent Cancer Research Studies Contained The Same Copied Results. How Does This Happen?
Eight Fraudulent Cancer Research Studies Contained The Same Copied Results. How Does This Happen?
Forbes
cancer
oncology
academic research
research fraud
Flag link:
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline
Xconomy
Cullinan Oncology
cancer
oncology
Flag link:
ASCO 2020 virtual annual meeting – day 1 (live updates)
ASCO 2020 virtual annual meeting – day 1 (live updates)
Pharmaforum
ASCO 2020
virtual meetings
oncology
cancer
COVID-19
pandemic
Flag link:
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
Fierce Pharma
cancer
JNJ
AbbVie
Roche
pharma advertising
oncology
Flag link:
With money flowing, Pliant Therapeutics heads to public well
With money flowing, Pliant Therapeutics heads to public well
Endpoints
IPOs
Pliant Therapeutics
Rare Diseases
oncology
Flag link:

Pages